Reduction in Arrhythmia Burden With Left Atrial Posterior Wall Ablation for Persistent AF

NCT05195268 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-09-29

No results posted yet for this study

Summary

RABLAP-AF will compare pulmonary vein isolation (PVI) in combination with posterior wall isolation (PWI) for patients with persistent atrial fibrillation (AF).

Conditions

Interventions

PROCEDURE

Intracardiac Catheter Ablation

Both arms will receive intracardiac catheter ablation procedures as described.

Sponsors & Collaborators

  • Biosense Webster, Inc.

    collaborator INDUSTRY
  • Royal Brompton & Harefield NHS Foundation Trust

    collaborator OTHER
  • St George's University Hospitals NHS Foundation Trust

    collaborator OTHER
  • University Hospital Plymouth NHS Trust

    collaborator OTHER
  • South Tees Hospitals NHS Foundation Trust

    collaborator OTHER
  • Manchester University NHS Foundation Trust

    collaborator OTHER_GOV
  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER
  • Papworth Hospital NHS Foundation Trust

    collaborator OTHER_GOV
  • Portsmouth Hospitals NHS Trust

    collaborator OTHER_GOV
  • University Hospitals Dorset NHS Foundation Trust

    collaborator OTHER_GOV
  • University Hospital Birmingham NHS Foundation Trust

    collaborator OTHER
  • Onze Lieve Vrouw Hospital

    collaborator OTHER
  • AZ Sint-Jan AV

    collaborator OTHER
  • University of Liverpool

    collaborator OTHER
  • Liverpool Heart and Chest Hospital NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dhiraj Gupta, MD · Liverpool Heart & Chest Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-09-12
Completion
2022-09-12

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05195268 on ClinicalTrials.gov